Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.
Otero R, Lobo JL, López R, Fernández C, Jiménez D, Muriel A, Alfonso M, Ballaz A, Núñez-Ares A, Rodríguez-Matute C, de Miguel-Díez J, Rodríguez-Chiaradía DA, Alcalde M, Elías T, Jara-Palomares L, Rivas A, Alonso Á, García-Ortega A, Sancho T, Morillo R, García-Bragado F, Hernández-Blasco L, Uresandi F, Madridano O, Agüero R, Monreal M; OSIRIS Investigators. Otero R, et al. Among authors: elias t. Thromb Res. 2023 Aug;228:1-9. doi: 10.1016/j.thromres.2023.05.005. Epub 2023 May 19. Thromb Res. 2023. PMID: 37263121 Free article.
Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism.
Jiménez D, Rodríguez C, León F, Jara-Palomares L, López-Reyes R, Ruiz-Artacho P, Elías T, Otero R, García-Ortega A, Rivas-Guerrero A, Abelaira J, Jiménez S, Muriel A, Morillo R, Barrios D, Le Mao R, Yusen RD, Bikdeli B, Monreal M, Lobo JL; IPEP investigators. Jiménez D, et al. Among authors: elias t. Eur Respir J. 2022 Feb 10;59(2):2100412. doi: 10.1183/13993003.00412-2021. Print 2022 Feb. Eur Respir J. 2022. PMID: 34385269 Free article. Clinical Trial.
Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study).
Otero R, Solier-López A, Sánchez-López V, Oto J, Arellano E, Marín S, Jara-Palomares L, Elías T, Asencio MI, Blasco-Esquivias I, Rodríguez de la Borbolla M, Sánchez-Díaz JM, Real-Domínguez M, García-Cabrera E, Rodríguez-Martorell FJ, Medina P. Otero R, et al. Among authors: elias t. Cancers (Basel). 2022 Jun 2;14(11):2771. doi: 10.3390/cancers14112771. Cancers (Basel). 2022. PMID: 35681751 Free PMC article.
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
Ghofrani HA, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberá JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Hoeper MM; NEW COLLABORATORS LIST. Ghofrani HA, et al. Respir Med. 2021 Mar;178:106220. doi: 10.1016/j.rmed.2020.106220. Epub 2020 Nov 12. Respir Med. 2021. PMID: 33540340 Free article.
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry.
Hoeper MM, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, Grünig E, Klose H, Halank M, Langleben D, Snijder RJ, Escribano Subias P, Mielniczuk LM, Lange TJ, Vachiéry JL, Wirtz H, Helmersen DS, Tsangaris I, Barberà JA, Pepke-Zaba J, Boonstra A, Rosenkranz S, Ulrich S, Steringer-Mascherbauer R, Delcroix M, Jansa P, Šimková I, Giannakoulas G, Klotsche J, Williams E, Meier C, Ghofrani HA; Collaborators list. Hoeper MM, et al. Respir Med. 2021 Feb;177:106241. doi: 10.1016/j.rmed.2020.106241. Epub 2020 Dec 3. Respir Med. 2021. PMID: 33422952 Free article.
137 results